皓元医药: 上海皓元医药股份有限公司第四届监事会第六次会议决议公告

Group 1 - The company held the sixth meeting of the fourth supervisory board on June 18, 2025, in Shanghai, which was legally convened and attended by all three supervisors [1][2] - The supervisory board voted unanimously to cancel the supervisory board in order to improve the corporate governance structure and comply with the new regulations effective from July 1, 2024, and March 28, 2025 [1][2] - The powers of the supervisory board will be transferred to the audit committee of the board of directors, and related supervisory board regulations will be abolished [1]